Tianyi Liu

机构：Hunan University, Shanghai Jiao Tong University, Kidney Research UK, Shanghai First People's Hospital, Children's Hospital of Fudan University, Changsha University of Science and Technology · ORCID：0009-0006-3733-8859

发表论文 20 篇 · 总被引 192 次 · h-index 6

代表论文

• Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy (2021 · Frontiers in Oncology · 被引 73)
• Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment (2022 · Frontiers in Oncology · 被引 35)
• Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis (2022 · Frontiers in Oncology · 被引 31)
• Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past (2021 · International Journal of Medical Sciences · 被引 14)
• TNFα-reliant FSP1 up-regulation promotes intervertebral disc degeneration via caspase 3-dependent apoptosis (2024 · Genes & Diseases · 被引 8)
• Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway (2024 · Biochemical and Biophysical Research Communications · 被引 7)